Cargando…
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35
[Image: see text] FK506-binding protein 35, FKBP35, has been implicated as an essential malarial enzyme. Rapamycin and FK506 exhibit antiplasmodium activity in cultured parasites. However, due to the highly conserved nature of the binding pockets of FKBPs and the immunosuppressive properties of thes...
Autores principales: | Atack, Thomas C., Raymond, Donald D., Blomquist, Christa A., Pasaje, Charisse Flerida, McCarren, Patrick R., Moroco, Jamie, Befekadu, Henock B., Robinson, Foxy P., Pal, Debjani, Esherick, Lisl Y., Ianari, Alessandra, Niles, Jacquin C., Sellers, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667655/ https://www.ncbi.nlm.nih.gov/pubmed/33209191 http://dx.doi.org/10.1021/acsmedchemlett.0c00272 |
Ejemplares similares
-
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
Phosphatidylinositol 3-phosphate and Hsp70 protect Plasmodium falciparum from heat-induced cell death
por: Lu, Kuan-Yi, et al.
Publicado: (2020) -
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992) -
Selective expression of variant surface antigens enables Plasmodium falciparum to evade immune clearance in vivo
por: Chew, Marvin, et al.
Publicado: (2022)